Savvy Extras, 6/21/22: From DiabetesMine D-Data Exchange 2022
DiabetesMine D-Data is an extraordinary semi-annual event that showcases significant and unique topics in diabetes technology and management, hosted by founder/T1D Amy Tenderich. This year’s virtual was, as always, informative, educational, and exciting to...
Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
Savvy Updates 6/8/22: More on Dexcom, CGM Accuracy Study, CGM Alarm Fatigue, Prior Authorizations Reform (NOT)
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
More Diabetes Blogs